A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed

A 40-year-old man with a diagnosis of lung adenocarcinoma (cT4N3M1c, stage IVB) experienced worsening of lymphangitic carcinomatosis in the right lung and right pleural effusion after receiving 1 cycle of first-line chemotherapy consisting of cisplatin and pemetrexed. Bevacizumab was thus added from...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsume, Maika, Honda, Takeshi, Haruyama, Terunobu, Ishihara, Masashi, Fukasawa, Yoko, Sakamoto, Takahiko, Tanzawa, Shigeru, Usui, Ryo, Ota, Shuji, Ichikawa, Yasuko, Watanabe, Kiyotaka, Seki, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836232/
https://www.ncbi.nlm.nih.gov/pubmed/29515397
http://dx.doi.org/10.1159/000484662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836232/
https://www.ncbi.nlm.nih.gov/pubmed/29515397
http://dx.doi.org/10.1159/000484662

Ejemplares similares